Acyclovir Completed Phase 3 Trials for Herpes Simplex Treatment

CompletedTreatment3 IdentifierTitleDrugs
NCT00004757Phase III Randomized, Placebo-Controlled Study of Acyclovir Oral Suspension for Neonatal Herpes Simplex Virus Infection Limited to the Skin, Eyes, and Mouth
NCT00031460Acyclovir for Herpes Infections Involving the Central Nervous System in Neonates
NCT00031447Acyclovir Herpes Simplex Virus (HSV) Skin, Eye, and Mouth
NCT00006135Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth